27386263|t|Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis
27386263|a|Recently, the number of follicular helper T (Tfh) cells expressing interleukin (IL)-21 was found to increase in peripheral blood of human and murine models of autoimmune hepatitis (AIH). IL-21, the most recently discovered member of the type-I cytokine family, exerts various effects on the immune system, including B cell activation, plasma cell differentiation, and immunoglobulin production. We aimed to assess the relationship of serum IL-21 levels in patients with type I AIH with clinical and laboratory parameters and histology. Ninety-two Japanese patients with liver disease (22 AIH, 20 primary biliary cholangitis, 19 drug-induced liver injury, 8 acute hepatitis B, 8 chronic hepatitis C, 10 non-alcoholic steatohepatitis, 5 viral hepatitis) and 10 healthy volunteers were recruited. Serum IL-21 levels were detected by enzyme-linked immunosorbent assay. Real-time polymerase chain reaction measured mRNA levels of Bcl-6, IL-21, and CXCR5 (Tfh-related factors) in peripheral mononuclear cells. Mean age at diagnosis of AIH was 58.6 years, male-to-female ratio was 4:18, 18.2 % of participants had cirrhosis, and 22.7 % had severe disease. IL-21 levels were significantly increased in the serum of patients with AIH compared to those with other liver diseases and controls (p < 0.0001). Particularly, serum IL-21 levels were significantly increased in severe AIH cases compared to non-severe cases (p < 0.05). Serum IL-21 levels correlated positively with total serum bilirubin levels (r = 0.46, p < 0.05), grading of necroinflammatory activity (r = 0.68, p < 0.005) and negatively with serum albumin levels in patients with AIH (r = -0.49, p < 0.05). In patients with biochemical remission of AIH, serum IL-21 levels remained elevated and correlated positively with serum IgG levels (r = 0.84, p < 0.01). Expression of Tfh-related factors, such as Bcl-6 and IL-21, in peripheral blood mononuclear cells of patients with AIH was significantly higher than that in healthy volunteers. IL-21 may play an important role in the pathogenesis and severity of AIH, and may present a promising target for AIH therapy.
27386263	0	14	Interleukin-21	T103	UMLS:C0962190
27386263	44	56	pathogenesis	T038	UMLS:C0699748
27386263	73	100	type I autoimmune hepatitis	T038	UMLS:C4303164
27386263	125	135	follicular	T017	UMLS:C1571705
27386263	136	156	helper T (Tfh) cells	T017	UMLS:C0018894
27386263	168	187	interleukin (IL)-21	T103	UMLS:C0962190
27386263	213	229	peripheral blood	T031	UMLS:C0229664
27386263	233	238	human	T204	UMLS:C0086418
27386263	243	249	murine	T204	UMLS:C0026809
27386263	250	256	models	T038	UMLS:C0012644
27386263	260	280	autoimmune hepatitis	T038	UMLS:C0241910
27386263	282	285	AIH	T038	UMLS:C0241910
27386263	288	293	IL-21	T103	UMLS:C0962190
27386263	338	360	type-I cytokine family	T103	UMLS:C0079189
27386263	392	405	immune system	T022	UMLS:C0020962
27386263	417	434	B cell activation	T038	UMLS:C1155003
27386263	436	463	plasma cell differentiation	T038	UMLS:C1817697
27386263	469	494	immunoglobulin production	T038	UMLS:C0003261
27386263	535	540	serum	T031	UMLS:C0229671
27386263	541	546	IL-21	T103	UMLS:C0962190
27386263	571	581	type I AIH	T038	UMLS:C4303164
27386263	600	610	laboratory	T092	UMLS:C0022877
27386263	626	635	histology	T091	UMLS:C0019638
27386263	648	656	Japanese	T098	UMLS:C1556094
27386263	671	684	liver disease	T038	UMLS:C0023895
27386263	689	692	AIH	T038	UMLS:C0241910
27386263	697	724	primary biliary cholangitis	T038	UMLS:C0008312
27386263	729	754	drug-induced liver injury	T038	UMLS:C0860207
27386263	758	775	acute hepatitis B	T038	UMLS:C0276609
27386263	779	798	chronic hepatitis C	T038	UMLS:C0524910
27386263	803	832	non-alcoholic steatohepatitis	T038	UMLS:C3241937
27386263	836	851	viral hepatitis	T038	UMLS:C0042721
27386263	860	878	healthy volunteers	T098	UMLS:C1708335
27386263	895	900	Serum	T031	UMLS:C0229671
27386263	901	906	IL-21	T103	UMLS:C0962190
27386263	931	964	enzyme-linked immunosorbent assay	T058	UMLS:C0014441
27386263	966	1001	Real-time polymerase chain reaction	T062	UMLS:C1709846
27386263	1011	1015	mRNA	T103	UMLS:C0035696
27386263	1026	1031	Bcl-6	T017	UMLS:C1332399
27386263	1033	1038	IL-21	T017	UMLS:C1416406
27386263	1044	1049	CXCR5	T017	UMLS:C1332421
27386263	1051	1070	Tfh-related factors	T103	UMLS:C0033684
27386263	1075	1085	peripheral	T082	UMLS:C0205100
27386263	1117	1126	diagnosis	T033	UMLS:C0011900
27386263	1130	1133	AIH	T038	UMLS:C0241910
27386263	1150	1170	male-to-female ratio	T033	UMLS:C0243095
27386263	1208	1217	cirrhosis	T038	UMLS:C0023890
27386263	1241	1248	disease	T038	UMLS:C0012634
27386263	1250	1255	IL-21	T103	UMLS:C0962190
27386263	1299	1304	serum	T031	UMLS:C0229671
27386263	1322	1325	AIH	T038	UMLS:C0241910
27386263	1411	1416	serum	T031	UMLS:C0229671
27386263	1417	1422	IL-21	T103	UMLS:C0962190
27386263	1469	1472	AIH	T038	UMLS:C0241910
27386263	1520	1525	Serum	T031	UMLS:C0229671
27386263	1526	1531	IL-21	T103	UMLS:C0962190
27386263	1572	1577	serum	T031	UMLS:C0229671
27386263	1578	1594	bilirubin levels	T058	UMLS:C0344395
27386263	1617	1654	grading of necroinflammatory activity	T033	UMLS:C1954433
27386263	1697	1717	serum albumin levels	T033	UMLS:C0728877
27386263	1735	1738	AIH	T038	UMLS:C0241910
27386263	1791	1800	remission	T033	UMLS:C0544452
27386263	1804	1807	AIH	T038	UMLS:C0241910
27386263	1809	1814	serum	T031	UMLS:C0229671
27386263	1815	1820	IL-21	T103	UMLS:C0962190
27386263	1861	1871	positively	T033	UMLS:C1514241
27386263	1877	1893	serum IgG levels	T058	UMLS:C2732508
27386263	1916	1926	Expression	T038	UMLS:C1171362
27386263	1930	1949	Tfh-related factors	T103	UMLS:C0033684
27386263	1959	1964	Bcl-6	T103	UMLS:C1448774
27386263	1969	1974	IL-21	T103	UMLS:C0962190
27386263	1979	2013	peripheral blood mononuclear cells	T017	UMLS:C1321301
27386263	2031	2034	AIH	T038	UMLS:C0241910
27386263	2073	2091	healthy volunteers	T098	UMLS:C1708335
27386263	2093	2098	IL-21	T103	UMLS:C0962190
27386263	2133	2145	pathogenesis	T038	UMLS:C0699748
27386263	2162	2165	AIH	T038	UMLS:C0241910
27386263	2206	2209	AIH	T038	UMLS:C0241910